VMP 39732811000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Anagrelide 500microgram capsules
BNF code 0901040A0AAAAAA
Virtual Therapeutic Moiety Anagrelide
Date identifier became valid 27 May 2021
Previous product identifier 374572004
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Anagrelide hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372561005
Strength value numerator 500.000
Strength value numerator unit microgram
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Anagrelide 500microgram capsules (A A H Pharmaceuticals Ltd)
Anagrelide 500microgram capsules (Alliance Healthcare (Distribution) Ltd)
Anagrelide 500microgram capsules (Consilient Health Ltd)
Anagrelide 500microgram capsules (Glenmark Pharmaceuticals Europe Ltd)
Anagrelide 500microgram capsules (Medihealth (Northern) Ltd)
Anagrelide 500microgram capsules (Milpharm Ltd)
Anagrelide 500microgram capsules (Sandoz Ltd)
Anagrelide 500microgram capsules (Torrent Pharma (UK) Ltd)
Anagrelide 500microgram capsules (Viatris UK Healthcare Ltd)
Anagrelide 500microgram capsules (Zentiva Pharma UK Ltd)
Xagrid 500microgram capsules (CST Pharma Ltd)
Xagrid 500microgram capsules (Takeda UK Ltd)
Virtual Medicinal Product Packs
Anagrelide 500microgram capsules 100 capsule

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback